Raymond James & Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-45,470
| Closed | -$231K | – | 3672 |
|
|
2019
Q4 | $231K | Buy |
45,470
+12
| +0% | +$61 | ﹤0.01% | 3234 |
|
|
2019
Q3 | $230K | Sell |
45,458
-2,027
| -4% | -$10.3K | ﹤0.01% | 3151 |
|
|
2019
Q2 | $293K | Sell |
47,485
-10,336
| -18% | -$63.8K | ﹤0.01% | 3009 |
|
|
2019
Q1 | $268K | Buy |
57,821
+5,781
| +11% | +$26.8K | ﹤0.01% | 3032 |
|
|
2018
Q4 | $219K | Sell |
52,040
-6,058
| -10% | -$25.5K | ﹤0.01% | 3063 |
|
|
2018
Q3 | $364K | Sell |
58,098
-13,488
| -19% | -$84.5K | ﹤0.01% | 2898 |
|
|
2018
Q2 | $576K | Buy |
71,586
+14,008
| +24% | +$113K | ﹤0.01% | 2579 |
|
|
2018
Q1 | $430K | Buy |
57,578
+4,572
| +9% | +$34.1K | ﹤0.01% | 2649 |
|
|
2017
Q4 | $315K | Sell |
53,006
-372
| -0.7% | -$2.21K | ﹤0.01% | 2791 |
|
|
2017
Q3 | $393K | Buy |
53,378
+1,102
| +2% | +$8.11K | ﹤0.01% | 2612 |
|
|
2017
Q2 | $355K | Buy |
52,276
+4,599
| +10% | +$31.2K | ﹤0.01% | 2609 |
|
|
2017
Q1 | $450K | Buy |
47,677
+3,653
| +8% | +$34.5K | ﹤0.01% | 2447 |
|
|
2016
Q4 | $380K | Buy |
+44,024
| New | +$380K | ﹤0.01% | 2492 |
|